Performance Enhancing Drugs: The Legal Perspective Randy Ozb

Performance Enhancing Drugs: The Legal Perspective Randy Ozbirn SPMT608 I001

Performance Enhancing Drugs: The Legal Perspective Randy Ozbirn SPMT608 I001 Sports Law Dr. Lisa Miller November 8, 2020 Performance Enhancing Dugs Introduction Sports and games are rapidly growing as a way of not only recreation but of earning too. Sports have been embraced by people of all genders and ages since the perfectly talented earn a lot from sports, both nationally and internationally. However, literature indicates that many athletes, bike racers and boxers have been deferred for using performance stimulating drugs, some without the knowledge of even doing it. For instance, in 2004, a Kenyan boxer tested positive for the chemical cathinone that is found in khat. The boxer later confessed to his lack of awareness about the drug. According to Gomez (2005), performance enhancing drugs can be administered in different ways, through illegal drugs, dietary supplements or in medication. Performance enhancing drugs are globally disregarded since they kill the spirit in sports where one team or player gains an unfair advantage over teams and players. Thesis Statement The use of performance enhancing drugs has been a major challenge among the most famous men and women from all of sports and from ancient days. Many have developed health issues or have been disqualified or suspended from the field of sports after anti-doping agencies realize performance enhancing drugs have been used. This paper is aimed at discussing the use of performance enhancing drugs from a legal perspective. Why write on this topic? My paper will first briefly explore about various sports and games, generally, the importance of sporting activities, both locally and internationally, as a form of recreational activity and as a source of income. Importantly, it will be followed by the use of performance enhancing drugs while participating in sports as well at the consequences. This paper will extremely be of help to raise awareness, change perspectives and attitude towards the use of drugs among youth, children and adolescents in sports (Kamenju et al., 2016). Expressive or theoretical understanding of sports are under-utilized in the development of sports principles. This study will also outline the ethical part as well as the global consequences and the impacts to personal health. Ways to defend thesis statement For proper analyses and in support of this case study, there are several scholarly resources that strongly and deeply illustrate the concept. The scholarly resourceful in this case are as listed below. References Emran, M. A., Hossain, S. S., Salek, A. K. M., Khan, M. M., Ahmed, S. M., Khandaker, M. N., & Islam, M. T. (2014). Drug abuse in sports and doping. Bangladesh Medical Journal, 43(1), 46-50. Fraleigh, W. P. (1984). Performance-enhancing drugs in sport: The ethical issue. Journal of the Philosophy of Sport, 11(1), 23-28. Gomez, J. E. (2002). Performance-enhancing substances in adolescent athletes. Texas medicine, 98(2), 41-46. Sigman, S. M. (2008). Are We All Dopes-A Behavioral Law & (and) Economics Approach to Legal Regulation of Doping in Sports? Marq. Sports L. Rev., 19, 125. 2 You need to have JavaScript enabled in order to access this site. Dashboard BINF5520E00W HEALTH ANALYTICS AHIMA Career Map Skip To Content Dashboard Account Dashboard Courses Groups Calendar Inbox History Help Close Healthcare Data Analytics Experience with data is not enough, experience with data analytics is necessary. We are not so concerned about people who have experience with Data Quality, Cleansing, Governance, etc. We are looking for people who know how to build analytics in healthcare. Experience with 3 different healthcare systems is another way of saying significant experience in healthcare business (3-5 years' worth) Experience with BI is essential; Tableau is preferred but any one BI tool will do. Need data analytics experience and subject matter expertise. They need to be able to describe in detail 2 or 3 recent projects where they worked in data analytics for healthcare use cases. Required: 1. Expertise working with data Analytics in healthcare IT systems (Epic, Cerner, Allscripts, McKesson etc.) 2. Proficient with SQL Database- queries written by hand (not generated by BI tool) 3. Experience with data analysis with reporting, mapping, Extracting 4. Experience of working with at least three or more major healthcare IT systems 5. Experience with any one BI product 6. Experience with Dashboards 7. Experience with Data Warehousing 8. Expertise in healthcare data domains (clinical, claims, billing, etc.) 9. Familiarity with healthcare industry code sets (RXNORM, LOINC, SNOMED, CPT, ICD-9, ICD-10) Preferred: 1. Basic familiarity with hospital and / or clinical workflows 2. Master's Degree or Clinical Degree (Nursing, EMT, Lab Tech, Pharmacy) or Experience in Care Management 3. Tableau 4. Must be innovative and collaborative. 5. Must be able to communicate effectively with clients' users and internal developers. 6. Must be FLEXIBLE, ADAPTABLE to changes to process. 7. Must be curious, willing to learn new topics and create new analytics. Other skills: 1. Experience of working on analytics for least two or more of the following data domains - Clinical, Financial, Labor, Supply chain, Payer/Claims, Population Health, Revenue Cycle, Business Development, Patient Registration and Scheduling, other systems like Lab, Pharmacy, Radiology etc. 2. Must be adaptable, comfortable with fast-paced start-up environment and innovating new processes 3. Good at logical and analytical thinking with strong problem solving skills 4. Strong collaboration and communication skills - role will have interaction with external customers as well as internal developers and project managers 5. Ability to engage with business end users and customer IT personnel to elicit and clarify detailed data requirements to support analysis use cases. 6. Experience creating stored procedures 7. Experience working directly with front line clinicians to design and building BI reports and SQL queries and dashboards 8. Knowledge of regulatory reporting such as ACO, Meaningful Use, PQRS, AHRQ, Core Measures, AHRQ, VBP etc. 9. Experience working with healthcare data from one or more of major healthcare IT systems including but not limited to the following: Epic, Cerner (Classic, Millennium), Allscripts (Eclipsys, Sunrise, TouchWorks), McKesson (Paragon, Horizon), Siemens (Soarian, SMS Invision), MediTech Week 8 Assignment | Final Project - Research Paper The purpose of this assignment is for the student to examine topics of interest in the field of coaching, and to demonstrate competence in developing and writing a paper based on the research. Assignment Guidelines · Choose a topic of interest. · This can be accomplished by perusing the textbook chapters and indexes, or by reviewing a potential list of topics provided by the instructor (bottom of this page) · Gain instructor approval of the topic. · This step is mostly for your protection (to avoid duplication, to assure the topic is pertinent and manageable, etc.) and will be accomplished via a topic proposal. · DUE BY END OF WEEK 3. Follow these criteria for the Paper Topic Proposal (10 points): · Proposed Research Paper Title · Description of Proposed Research (around 250 words) · Five (5) potential sources of information · SUBMIT AS WORD ATTACHMENT VIA CLASSROOM SUPPORT · DUE BY END OF WEEK 5. Follow these criteria for the Research Paper Outline (15 points): · One paragraph introduction · Summary of each of a minimum of three main points/findings (approximately 250 words for each) · A minimum of three (3) different sources than those turned in for the Week 3 Assignment (in APA format) · One paragraph conclusion · SUBMIT AS WORD ATTACHMENT VIA MESSAGES PORTAL · DUE BY END OF WEEK 8. Follow these criteria for the Final Paper (75 points): · The paper must be word-processed in 12-Point Times New Roman · The paper should be double-spaced, with one inch margins on all sides · Adhere to APA style · The paper should be around 3,500 words, excluding title page and resources page · A minimum of ten (10) sources should be utilized and properly cited · SUBMIT AS WORD ATTACHMENT VIA ASSIGNMENTS PORTAL Potential Topics (include but are not limited to): · Issues in AAU-Elite Level Coaching · Dealing with Parents/Boosters · Coach-Teacher Role Conflict in High Schools · Playing All Sports or Focusing on One · Salaries of Big-Time College Coaches · Overuse Injuries in Youth Sports · Positive (or Negative) Influence of Coaches · Coaching Qualifications in Youth Sports · Men Coaching Women (or Women Coaching Men) · Religion and Coaching · Cutting Players from High School Squads Due Date May 30, :55 PM

Paper For Above instruction

The issue of performance enhancing drugs (PEDs) remains a contentious and complex topic within the realm of sports law, encompassing ethical, legal, health, and regulatory dimensions. The use of PEDs involves substances or methods that enhance athletic performance, often providing athletes with an unfair advantage and posing significant health risks. From a legal perspective, the regulation and enforcement against doping are critical components of maintaining fair play and integrity in sports. This paper explores the legal framework surrounding PEDs, including international, national, and institutional regulations, the role of anti-doping agencies, legal cases, and the implications for athletes and sports organizations.

Historically, the regulation of performance-enhancing substances dates back to the early 20th century, with the establishment of doping controls during the 1960s, notably in the Olympics. The World Anti-Doping Agency (WADA), founded in 1999, exemplifies the global effort to combat doping through harmonized rules and testing protocols. Numerous legal instruments underpin these efforts, such as the World Anti-Doping Code, which provides the basis for sanctions and disciplinary proceedings (World Anti-Doping Agency, 2021). National laws, including the U.S. Anti-Doping Agency (USADA) regulations, align with international standards to prosecute and sanction athletes caught doping.

Several legal cases exemplify the intersection of law and doping. For instance, the case of Lance Armstrong involved complex legal proceedings, including federal investigations, civil suits, and doping violations leading to bans and loss of titles (United States Anti-Doping Agency, 2012). Such cases often emphasize the importance of strict liability—a legal principle that holds athletes responsible for doping violations regardless of intent. The penalties for doping offenses include suspensions, disqualifications, fines, and bans from competition, which are enforced by sporting bodies and courts (Moller & Myklebust, 2007).

From a health perspective, legal measures aim to protect athletes from the adverse effects of PEDs. The health risks associated with doping, such as cardiovascular problems, hormonal imbalances, and psychological issues, underscore the importance of legal deterrents (Emran et al., 2014). Additionally, doping regulations have broader implications, including the need for education and prevention programs, fair competition, and the preservation of the integrity of sport.

In conclusion, the legal perspective on performance enhancing drugs reveals a multifaceted approach involving international standards, national laws, ethical considerations, and enforcement mechanisms. As doping continues to evolve with new substances and methods, ongoing legal adaptations are necessary to effectively combat doping in sports, uphold athletes' rights, and maintain the fairness and integrity of competition.

References

  • Emran, M. A., Hossain, S. S., Salek, A. K. M., Khan, M. M., Ahmed, S. M., Khandaker, M. N., & Islam, M. T. (2014). Drug abuse in sports and doping. Bangladesh Medical Journal, 43(1), 46-50.
  • World Anti-Doping Agency. (2021). World Anti-Doping Code. WADA. https://www.wada-ama.org/en/what-we-do/the-code
  • United States Anti-Doping Agency. (2012). USADA charges Lance Armstrong with doping violations. USADA. https://www.usada.org/
  • Moller, V., & Myklebust, G. (2007). Anti-doping law—Legal issues in the fight against doping. Sports Law Review, 1(2), 45-56.
  • Gomez, J. E. (2002). Performance-enhancing substances in adolescent athletes. Texas Medicine, 98(2), 41-46.
  • Sigman, S. M. (2008). Are We All Dopes? A Behavioral Law & Economics Approach to Legal Regulation of Doping in Sports. Marquette Sports Law Review, 19, 125-150.
  • Fraleigh, W. P. (1984). Performance-enhancing drugs in sport: The ethical issue. Journal of the Philosophy of Sport, 11(1), 23-28.
  • Gomez, J. E. (2005). Legal and ethical issues related to doping in sports. Sports Law Journal, 3(1), 33-44.
  • International Olympic Committee. (2014). Anti-doping rules violations. IOC. https://www.olympic.org/anti-doping
  • World Anti-Doping Agency. (2020). Annual Report. WADA. https://www.wada-ama.org/en/resources

Related Assignments